- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03865329
Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)
Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Despite proven benefits, the proportion of people with COPD who receive Pulmonary Rehabilitation (PR) is very small. The current model of a center-based PR program fails to address the needs of many patients with COPD. The most common patient barrier to attendance is travel to center-based programs, particularly for frail patients with more severe COPD who need transportation assistance. Home-based, unsupervised PR has been proposed as an alternative model to hospital-based programs and has been found to be safe and effective.
In this pilot study researchers will investigate barriers, facilitators and adherence to a home-based pulmonary rehabilitation program after hospitalization. The results of this pilot study will inform the second part of this study as a randomized control study under a different grant (Study 2/R33). Both quantitative and qualitative methods will be used for the evaluation.
10 patients will be enrolled in this pilot study and allocated to a home-based PR in order to polish the intervention before the randomized portion of the study. This pilot is supported by a grant mechanism (R61) explicitly oriented to adjust the intervention and identify barriers for the next randomized portion of this study (Study 2) supported by a separate grant mechanism (R33).
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Minnesota
-
Rochester, Minnesota, Estados Unidos, 55905
- Mayo Clinic in Rochester
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria
- COPD related hospitalization and eligible for PR
- Age 40+
- Confidence (score > 5 in a self-efficacy question (1-10 scale): how confident you feel to use this system on a daily basis)
Exclusion Criteria
- Inability to walk (orthopedic-neurologic problems or confined to bed)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervention- Home Pulmonary Rehabilitation
Participants will be offered a Home-based pulmonary rehabilitation program with health coaching.
|
Reabilitação pulmonar (RP) domiciliar com treinamento em saúde usando um sistema remoto que permitirá que os pacientes concluam a RP em casa.
O programa envolve exercícios de membros superiores e inferiores, auto-relato de sintomas (fadiga, falta de ar, atividade física e bem-estar geral).
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Adherence to One Balance Practice Routine
Prazo: Baseline to 3 months
|
Percentage of participants to adhere to one balance practice routine per day for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
|
Adherence to Two Balance Practice Routine
Prazo: Baseline to 3 months
|
Percentage of participants to adhere to two balance practices routine per day for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
|
Adherence to Daily Flexible Practice Routine
Prazo: Baseline to 3 months
|
Percentage of participants to adhere to the daily flexible practice routine for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
|
Completion of the Daily Self-assessment
Prazo: Baseline to 3 months
|
Percentage of participants to complete the daily self-assessment for 6 out of the 7 days for 12 weeks via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Chronic Respiratory Questionnaire (CRQ) Physical Symptoms Summary
Prazo: Baseline, 3 months
|
The CRQ is a 20-question inventory assessing the areas of health related quality of life in dyspnea (shortness of breath), fatigue, emotion, and feelings of mastery of chronic respiratory disease.
The Physical Summary score includes dyspnea (symptom #1 in COPD) and fatigue (symptom #2 in COPD) domains.
The questions in each domain are added together and then divided by the number of questions.
The possible range is 1-7, where 1 is the worst and 7 the best.
|
Baseline, 3 months
|
|
Change in Chronic Respiratory Questionnaire (CRQ) Emotional Symptoms Summary
Prazo: Baseline, 3 months
|
The CRQ Emotion Summary score includes the emotion (independent factor for admissions and poor quality of life) and mastery (self-management) domains of the CRQ.
The scores for each domain are calculated by simply added together the answers and then dividing by the number of questions, the range is 1-7 where 1 is the worst and 7 the best.
|
Baseline, 3 months
|
|
Daily Physical Activity
Prazo: 3 months
|
Average number of steps per day recorded by ActiGraph activity monitor worn on the wrist for seven days at 3 months
|
3 months
|
|
Change in the Self-Management Ability Scale (SMAS) Total Score
Prazo: Baseline, 3 months
|
Measured using the total score from the self-reported SMAS 30 item questionnaire that measures ability and function.
A higher score indicates more ability and function in everyday life.
The SMAS30 has six areas, each with 5 questions.
The minimum score is one and the max is 5.
The mean is calculated for each section.
A higher score indicates better self management.
|
Baseline, 3 months
|
|
Change in Patient Health Questionnaire (PHQ-2)
Prazo: Baseline, 3 months
|
Measured using the self-reported PHQ-2 consisting of a 2 item questionnaire inquiring about the frequency of depressed mood over the past 2 weeks on a scale of 0 to 3, 0=Not at all, 1=several days, 2=more than half the days, 3=nearly everyday.
The minimum score is zero and the highest score is 6.
A score greater than 3 may indicate depression.
|
Baseline, 3 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Roberto P Benzo, MD, Mayo Clinic
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- 18-002453 (Pilot Study/R61)
- R61HL142933 (Concessão/Contrato do NIH dos EUA)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .